See also this year's filing and all EDGAR filings for this company.
PDF Report 0001799191_2023_Oncology_Institute_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.28627505419287325, 'aggregate_val': 334191000, 'exp_sum': 468235000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 119689000, 'GoodwillImpairmentLoss': 9944000, 'OperatingCostsAndExpenses': 334434000, 'DepreciationDepletionAndAmortization': 4411000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -243000}} |
Graph
Absolute values for 0001799191, Oncology Institute Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 39,375,000 |
| 1 | AssetsNonCurrent | 24,971,000 |
| 2 | AssetsCurrent | 130,418,000 |
| 3 | PropertyPlantAndEquipment | 8,547,000 |
| 4 | remainder_Assets | 58,354,000 |
| 5 | LongTermLiabilities | 103,549,000 |
| 6 | LiabilitiesCurrent | 29,828,000 |
| 7 | remainder_Liabilities | 5,113,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 119,689,000 |
| 11 | GoodwillImpairmentLoss | 9,944,000 |
| 12 | OperatingCostsAndExpenses | 334,434,000 |
| 13 | DepreciationDepletionAndAmortization | 4,411,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -134,287,000 |
| 17 | remainder_Revenues | 252,483,000 |
| 18 | remainder_NetIncome | 81,860,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 261,665,000 |
| 1 | Liabilities | 138,490,000 |
| 2 | Expenses | 334,191,000 |
| 3 | Revenues | 252,483,000 |
| 4 | StockholdersEquity | 123,175,000 |
| 5 | NetIncome | 152,000 |
| 6 | ComprehensiveNetIncome | 152,000 |
| 7 | BaseVar | 644,652,610 |
| 8 | EconomicCapitalRatio | 1.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
